NZT is thallanylzirconio-methyl-tetrahydro-triazatriphenylene, a powerful new class of psychotropic medication that merges various features of NDRI’s, NaSSA’s and SSRI’s. NZT works, in part, by maintaining higher levels of 5-HT in the synapse while increasing norepinephrine and serotonin neurotransmission by blocking presynaptic alpha-2 adrenergic receptors while at the same time blocking certain serotonin receptors.